{"title":"Procept BioRobotics vs Stryker: Medical & surgical compared","url":"https://www.frontiertechintelligence.com/compare/procept-biorobotics-vs-stryker","comparison":"Stryker ranks 29 on the Robotics 100 with a score of 86; Procept BioRobotics ranks 88 with 78. Stryker is ahead on positioning, firepower and leverage. Level on deployment, production, commercials, progress and technology. Procept BioRobotics is based in San Jose, United States, Stryker in Portage, United States. Procept BioRobotics: Established. Stryker: Established. Procept BioRobotics is named in 9 signals and Stryker in 10.","companies":[{"name":"Procept BioRobotics","url":"https://www.frontiertechintelligence.com/companies/procept-biorobotics","city":"San Jose","country":"United States","stage":"Established","founded":null,"last_round":null,"positioning":"Procept BioRobotics is a US surgical-robotics maker whose Aquablation system runs about 12,200 US procedures a quarter, with FY26 guidance of $390-410M (+27-33%). It gained FDA clearance for its second-generation FirstAssist AI in Q1-26, an EAU guideline recommending Aquablation over TURP, and its first UK Hydros units at ASPs above $400k. It is not yet profitable (Q1-26 net loss widened to $31.6M), with adjusted-EBITDA breakeven targeted for Q4-26.","assessed_in":{"domain":"Robotics","list":"Robotics 100","rank":88,"score":78,"tier":"member","scores":{"gate_ne":["technology","firepower"],"leverage":6,"position":8,"progress":8,"firepower":8,"commercial":8,"deployment":8,"production":8,"technology":8},"why":"Procept BioRobotics develops and sells robotic surgical systems for urologic procedures, including the AquaBeam Robotic System for waterjet ablation in benign prostatic hyperplasia treatment.","segment":"Medical & surgical","layer":"Systems"},"signals_total":9,"facts_total":2},{"name":"Stryker","url":"https://www.frontiertechintelligence.com/companies/stryker","city":"Portage","country":"United States","stage":"Established","founded":null,"last_round":null,"positioning":"Stryker's Mako surgical-robotics franchise (within the ortho segment of Nasdaq:SYK) has 3,000+ systems installed and 2.5M procedures across 47 countries, with more than two-thirds of US Stryker knee procedures now robotic. It moved the handheld Mako RPS from limited release (February 2026) to full US launch (July 2026) with an ambulatory-surgery-center push, alongside Mako 4 multi-specialty and a shoulder application. Mako-specific figures are group-scoped and not separately disclosed.","assessed_in":{"domain":"Robotics","list":"Robotics 100","rank":29,"score":86,"tier":"member","scores":{"gate_ne":["technology","firepower"],"leverage":8,"position":10,"progress":8,"firepower":10,"commercial":8,"deployment":8,"production":8,"technology":8},"why":"Stryker sells Mako SmartRobotics and handheld robotic systems that assist surgeons in joint replacement and other orthopaedic procedures.","segment":"Medical & surgical","layer":"Systems"},"signals_total":10,"facts_total":69}],"note":"Assessment by Frontier Tech Intelligence; facts and signals carry their sources."}